AI Diagnostic Assistance: What Clinicians Should Know
What AI diagnostic and decision-support tools do, where the evidence is strong and weak, and how to evaluate one before it touches patient care.
AI tools that suggest diagnoses, flag risk or read images are getting a lot of attention. Some have solid evidence behind them in narrow tasks. Others have performed worse in real clinical use than their developers expected. Here's a practical overview for clinicians deciding how, and whether, to use them.
The Diagnostic Challenge
Diagnosis is hard, and errors are common enough to matter:
- A 2014 study by Singh and colleagues in BMJ Quality & Safety estimated that about 12 million US adults experience a diagnostic error in outpatient care each year.
- The National Academies' 2015 report Improving Diagnosis in Health Care concluded that most people will experience at least one diagnostic error in their lifetime.
- Cognitive biases, time pressure and incomplete information all contribute.
That's the problem AI diagnostic tools aim to help with.
What These Tools Do
"AI diagnostic assistance" covers several different kinds of tools:
Image and Signal Analysis
Software that reads images or tracings, for example retinal photos, radiology images, skin photos or ECGs, and flags likely abnormalities. This is the most mature area. In 2018 the FDA authorized the first autonomous AI system to detect diabetic retinopathy from retinal images in primary care.
Risk Prediction
Models that look at chart data, such as vital signs and lab results, and alert clinicians to patients at higher risk of a problem like sepsis or deterioration.
Differential Diagnosis Suggestions
Tools that take symptoms and history and suggest possible diagnoses for the clinician to consider.
Medication Safety Checks
Rule-based checks for drug interactions, allergies and dosing. These are often grouped with AI, although most rely on curated rules rather than machine learning.
What the Evidence Shows
- Narrow, well-defined tasks do best. Tools built for one clear question, like "is diabetic retinopathy present in this image?", have the strongest validation.
- Real-world performance can fall short. A 2021 external validation published in JAMA Internal Medicine found that a widely used proprietary sepsis prediction model missed many sepsis cases and generated many alerts, performing considerably worse than its developer had reported.
- Results don't always transfer. A model trained on one population or health system may perform differently on another.
- Alert fatigue is real. A tool that fires too often gets ignored, including when it's right.
The takeaway: judge each tool by independent evidence in settings like yours, not by general claims about AI.
A Note on Behavioral Health
Psychiatric diagnosis depends on history, observation and clinical judgment over time. Validated screeners like the PHQ-9 and GAD-7 are useful for tracking symptoms, but they're screening tools, not diagnoses. Be especially cautious with any tool that claims to assign a diagnosis or a suicide risk level automatically. Risk assessment should stay a documented clinical judgment.
Where Jogaza Fits, and Where It Doesn't
Jogaza EHR is built for psychiatric and behavioral health practices. It does not offer diagnostic suggestions, differential diagnoses, clinical decision support or drug-interaction checking. Diagnosis stays with the clinician.
What Jogaza's AI scribe does is documentation:
- After the clinician confirms the patient agreed to be recorded, it records the visit, transcribes it and drafts a note in the clinician's voice.
- It never assigns a suicide or violence risk level and never invents a medication dose. Anything not discussed is marked as not discussed rather than guessed.
- The clinician reviews and edits every draft before saving.
Jogaza also scores PHQ-9, GAD-7 and other validated screeners automatically and charts them over time, presenting the scores as screening results, not diagnoses.
Questions to Ask Before Adopting a Diagnostic AI Tool
Evidence
- What is the tool's regulatory status? Is it FDA-cleared or authorized for this use?
- Has it been validated independently, outside the developer's own data?
- Was it tested on patients like yours, in a setting like yours?
- What are its sensitivity, specificity and false-alert rate?
Transparency
- Does it show why it made a suggestion?
- Is it clear what data it used?
- Who is told when the model is updated, and how?
Workflow
- Where does it appear, and does it interrupt at the right moment?
- How often will it alert, and who is expected to act?
- Can clinicians easily record that they considered and overrode a suggestion?
Privacy and Contracts
- What patient data does it receive, and where is it processed and stored?
- Is the data used to train the vendor's models?
- Will the vendor sign a Business Associate Agreement?
Using AI Tools Safely
- Treat outputs as suggestions. The clinician remains responsible for the diagnosis and the plan.
- Know the limits. Understand what the tool was designed and validated for, and don't stretch it beyond that.
- Watch for bias. Check whether performance differs across patient groups.
- Be open with patients. Let patients know when AI tools are part of their care, and follow your state's rules on disclosure and consent.
- Report problems. Feed errors and near misses back to the vendor and your own quality process.
Ethical Considerations
Accountability
AI tools don't carry clinical responsibility. The clinician does, which is why understanding a tool's limits matters.
Equity
Models trained on unrepresentative data can perform worse for some patient groups. Ask vendors how they've tested for this.
Privacy
Patient data sent to an AI service should be covered by appropriate agreements and protected with the same care as the rest of the record.
Getting Started
- Define the problem. Pick a specific clinical question where errors or delays are a real issue for your practice.
- Look for evidence first. Favor tools with independent validation for that exact use.
- Pilot carefully. Start with a limited rollout and compare the tool's suggestions against clinician judgment.
- Monitor. Track alert volume, overrides and any errors found, and be ready to switch the tool off if it isn't helping.
Conclusion
AI diagnostic tools can be useful for narrow, well-validated tasks, and less reliable than advertised in others. Treat each tool as something to evaluate on evidence, keep clinical judgment at the center and be clear with patients about how technology is used in their care.
If your main burden is documentation rather than diagnosis, an AI scribe that drafts notes for your review is a different, more limited kind of tool.